Last Friday, affected by conflicts in the Middle East, US stocks opened lower and closed weaker, with all three major indices finishing down. The Nasdaq fell more than 2%. On a weekly basis, the Dow Jones dropped 2.11%, the S&P 500 declined 1.9%, and the Nasdaq fell 2.07%. All three indices recorded their fourth consecutive week of losses. Notably, the S&P 500 marked its longest weekly losing streak since March 2025, while the Dow saw its longest losing streak since February 2023.
At present, the conflict in the Middle East remains a core focus for Wall Street.Investors are closely monitoring the developments of the situation and the ripple effects of surging energy prices, keeping market sentiment highly tense. As the conflict enters its third week, international oil prices have surged over 40%, raising concerns among governments and central banks worldwide about rising inflation and economic stagnation.
Given the current backdrop, ARK is divesting from pure hardware tools and partially cashing out of crypto infrastructure to aggressively embrace software ecosystems with 'high-frequency AI synergy' and underlying data platforms that now offer exceptional value.

Buying Direction: Heavily investing in the 'AI Collaborative Design' super ecosystem.
The buying activity on the day showed tremendous momentum, with a significant position established in a collaborative software giant that directly ignited market activity.
Cathie Wood aggressively bought a UI/UX design collaboration software giant in a single day, $Figma Inc (FIG.US)$ acquiring up to 337,400 shares, marking an extremely bold cross-sector allocation.Figma is not just fundamental infrastructure for designers worldwide; after fully integrating generative AI, it has completely reshaped the productivity loop from code generation to UI interfaces. Buying Figma essentially means acquiring the high-frequency usage data of tens of millions of digital creators globally and the strong SaaS network effect. This also marks ARK identifying a core asset in the software sector that can truly deliver on the 'AI cost reduction and efficiency enhancement' dividend.
Furthermore, following the surprise purchase of 90,000 shares last Thursday, ARK continued to aggressively buy up to 192,700 shares of the single-cell sequencing giant on Friday. $10x Genomics (TXG.US)$ Up to 192,700 shares.If Thursday’s move was a tactical probe, today’s significant addition of nearly 200,000 shares firmly confirms ARK's "reversal revaluation" of TXG. Following the previous panic-driven sell-off, TXG’s core value as a foundational spatial biology and single-cell sequencing data provider is starting to shine through. Without TXG’s vast micro-cellular data, advanced AI pharmaceutical models would lose their essential training ground.
Cathie Wood also increased her position in an mRNA drug and vaccine development company by $Arcturus Therapeutics (ARCT.US)$ 22,800 shares. This marks the third consecutive trading day of adding to this position, showcasing strong belief in 'curative foundational therapies.'
Sell-side: Continuing to unload healthcare hardware, reducing exposure to crypto-related names.
On the sell-side, ARK's cleansing actions remain ruthless and efficient, with continued offloading of healthcare hardware while starting to take profits in some cryptocurrency and fintech infrastructure positions at higher levels.
Cathie Wood aggressively sold a portable ultrasound device company $Butterfly Network (BFLY.US)$ 182,400 shares, while also cutting her stake in a cancer early detection company $Guardant Health (GH.US)$ by 9,621 shares.This once again confirms the core argument in recent times: capital is mercilessly abandoning 'detection tools' that lack data barriers. Whether it's BFLY’s handheld ultrasound devices or GH’s liquid biopsy diagnostics, if they cannot master a complete technological closed-loop from identifying problems to solving them (such as CRISPR, mRNA), standalone hardware products are highly susceptible to falling into the quagmire of valuation shrinkage in the AI era.
In addition,Cathie Wood sells cryptocurrency exchange $Bullish (BLSH.US)$ 103,400 shares, and stablecoin issuer $Circle (CRCL.US)$ 46,000 shares.Amidst the recent sharp fluctuations in the crypto market, ARK has chosen to take profit and reduce positions in the infrastructure segment of digital assets (exchanges and stablecoins) in order to reallocate resources toward more certain AI software (like Figma).
Finally, ARK also reduced its holdings in automated testing equipment company $Teradyne (TER.US)$ by 19,200 shares. This continues the logic of capital rotation from 'upstream components and testing equipment' towards 'terminal AI carriers.'

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments (7)
to post a comment
19
78
